With at least 50 investments in startups across Asia, the US, Europe, and Australia, Temasek Holdings has continued to be one of the most active state investors, amid a year of market volatility and broad economic uncertainty.
While the cheque sizes and investment stages that the Singapore state investor participated in varied, it appears to have a preference for biotech and healthcare businesses, as well as alternative proteins and other decarbonisation efforts.